# DoW Vision, Clinical Trial Award (HT942526VRPCTA)

**Plain-English Eligibility Score:** 43/100

| Field | Value |
|---|---|
| Opportunity number | HT942526VRPCTA |
| Title | DoW Vision, Clinical Trial Award |
| Agency | Defense Health Agency Contracting Activity - DHACA |
| Status | posted |
| Posted / open date | 2026-05-05 |
| Close date | 2026-11-12 |
| Award ceiling | n/a |
| Award floor | n/a |
| Estimated total funding | $2,600,000 |
| Funding category | Science and Technology and other Research and Development |
| Eligible applicants | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility" |
| CFDA / Assistance listing | 12.420 |
| Summary | Summary: The fiscal year 2026 (FY26) Vision Research Program (VRP) Clinical Trial Award (CTA) supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of service-connected eye injury and visual dysfunction. Research must align with at least one of the FY26 VRP Focus Areas . Distinctive Features: · For interventions that require Investigational New Drug (IND)/Investigational Device Exemption (IDE) or equivalent regulatory authorizations for clinical testing, the IND/IDE application or equivalent must be submitted to the relevant Regulatory Agency by the CTA application submission deadline. In addition, applicants must  |
| Agency contact | help@eBRAP.org |

## Why this score
- Eligibility is unrestricted.
- Only 7 days until the deadline.

Source: Grants.gov (U.S. Department of Health and Human Services) (https://www.grants.gov/search-results-detail/362183). Last refreshed: 2026-11-03T18:08:06.385Z.
Data from Grants.gov. Always read the full notice of funding opportunity before applying. Informational only; not legal or grant-writing advice.